Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial

Wiviott S. D., White H. D., Ohman E. M., Fox K. A. A., Armstrong P. W., Prabhakaran D., ...Daha Fazla

LANCET, cilt.382, sa.9892, ss.605-613, 2013 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 382 Sayı: 9892
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/s0140-6736(13)61451-8
  • Dergi Adı: LANCET
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.605-613
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background Treatment with prasugrel and aspirin improves outcomes compared with clopidogrel and aspirin for patients with acute coronary syndrome who have had angiography and percutaneous coronary intervention; however, no clear benefit has been shown for patients managed first with drugs only. We assessed outcomes from the TRILOGY ACS trial based on whether or not patients had coronary angiography before treatment was chosen.